Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Astrazeneca, BBS-Bioactive Bone Substitutes, Biotricity, Bitmedical, Bristol-Myers Squibb, Broad Institute, Bruker, Cardiofocus, GHGK, Global Medical Supply, Grail, Helius Medical Technologies, Helix, Histosonics, Illumina, Inovytec, Kura Oncology, Li-Cor Biosciences, Merck, Microport CRM, Microsoft, Milestone Scientific, Myriad Genetics, Pixcell Medical, Polarityte, Precision Biologic, Protom, Rakuten Medical, Roche, Seer, Triolab, Verily Life Sciences.

Med-tech firms raising money in public or private financings, including: Bioaesthetics, Bioderm, Flurotech, Noctrix Health, Viewpoint Molecular Targeting.

New hires and promotions in the med-tech industry, including: Cynosure, Cytosorbents, Deepcell, Seastar Medical, Voxneuro.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerie, Amydis, Axcella, Boehringer, Chipscreen, Cytokinetics, Editas, Eli Lilly, Ideaya, Istari, Exicure, Lysogene, Neuren, Obseva, Organogenesis, RDIF, Receptor Life Sciences, Roche.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anavex, Baxter, Biogen, Bioinvent, Cohbar, Curevac, Cyclolab, Dyne, Epipharma, Exuma, Geovax, Hoth, Humanigen, Legochem, Maxcyte, Mirati, Moderna, Myeloid, Navrogen, Novavax, Opiant, Pharmabcine, Resolution Bioscience, Targetrin.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Aptevo, Aslan, Biomarin, Can-Fite, Cara, Celon, Codagenix, Dalcor, Dr. Reddy's, Edesa, Inflarx, Jupiter Orphan, Kintor, Lilly, Mediwound, Mesoblast, Neurorx, Oric, Redhill, Relief, Ultimovacs.

Biopharmas raising money in public or private financings, including: Affimed, Aileron, Ascendis, Atalanta, Biogen, Eqrx, Evaxion, Immunocore, Roche, Sensei, Tonix, Valo, Visen.

New hires and promotions in the biopharma industry, including: Arcutis, Biocardia, City of Hope, Deinove, Denali, Dyadic, Intercept, Modulus Oncology, Mydecine, Valneva, Xbrane, Ziphius Vaccines.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA formally posts testing advisory after town hall discussion; HHS finalizes regulatory review rule; Lab in California hit for three months of false claims; BVMed calls for German med tech strategy.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inari Medical.